From drug pricing and 'biosimilars' to opioids and culture — a wrap and podcast from biotech's big conference
It could be weeks or a year before the deals that biotech executives and financiers started at last week's 36th J.P. Morgan Healthcare Conference come to fruition. But here's a quick wrap — and a BioFlash podcast — of tidbits from Bay Area companies:
BAGGING OPIOIDS
McKesson Corp. (NYSE: MCK), the San Francisco-based health care products distribution company, has been a target of those looking to find a source of the nation's epidemic of pain-killing opioid drugs. But Chairman and CEO John…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ron Leuty Source Type: news
More News: Biotechnology | Conferences | Epidemics | Epidemiology | Health Management | Pain | Podcasts